- Home
- AEON vs TNON Comparison
AEON vs TNON Comparison
Compare AEON & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEON
- TNON
- Stock Information
- Founded
- AEON N/A
- TNON 2012
- Country
- AEON United States
- TNON United States
- Employees
- AEON N/A
- TNON N/A
- Industry
- AEON Biotechnology: Pharmaceutical Preparations
- TNON Medical Specialities
- Sector
- AEON Health Care
- TNON Health Care
- Exchange
- AEON Nasdaq
- TNON Nasdaq
- Market Cap
- AEON 8.0M
- TNON 6.9M
- IPO Year
- AEON N/A
- TNON 2022
- Fundamental
- Price
- AEON $0.81
- TNON $1.02
- Analyst Decision
- AEON Strong Buy
- TNON Strong Buy
- Analyst Count
- AEON 1
- TNON 3
- Target Price
- AEON $360.00
- TNON $11.67
- AVG Volume (30 Days)
- AEON 213.7K
- TNON 165.8K
- Earning Date
- AEON 08-11-2025
- TNON 08-12-2025
- Dividend Yield
- AEON N/A
- TNON N/A
- EPS Growth
- AEON N/A
- TNON N/A
- EPS
- AEON 117.22
- TNON N/A
- Revenue
- AEON N/A
- TNON $3,284,000.00
- Revenue This Year
- AEON N/A
- TNON $46.26
- Revenue Next Year
- AEON N/A
- TNON $58.02
- P/E Ratio
- AEON $0.01
- TNON N/A
- Revenue Growth
- AEON N/A
- TNON 2.18
- 52 Week Low
- AEON $0.38
- TNON $0.85
- 52 Week High
- AEON $269.28
- TNON $15.79
- Technical
- Relative Strength Index (RSI)
- AEON 56.89
- TNON 50.94
- Support Level
- AEON $0.80
- TNON $0.96
- Resistance Level
- AEON $0.87
- TNON $1.14
- Average True Range (ATR)
- AEON 0.06
- TNON 0.07
- MACD
- AEON -0.00
- TNON 0.01
- Stochastic Oscillator
- AEON 61.23
- TNON 50.00
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.